Synthesis of [ 11C]interleukin 8 using a cell-free translation system and l-[ 11C]methionine

Nuclear Medicine and Biology

Volumn 39, Issue 1, 2012, Pages 155-160

  Harada, Ryuichi ^a   Furumoto, Shozo ^a,b   Yoshikawa, Takeo ^a   Ishikawa, Yoichi ^b   Shibuya, Katsuhiko ^a   Okamura, Nobuyuki ^a   Iwata, Ren ^b   Yanai, Kazuhiko ^a,b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Carbon 11; Cell free protein synthesis; Imaging; Interleukin 8; Positron; Unnatural amino acid

Indexed keywords

INTERLEUKIN 8 C 11; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT; INTERLEUKIN 8; METHIONINE;

ANIMAL EXPERIMENT; ARTICLE; CATION EXCHANGE; CELL FREE SYSTEM; CHEMICAL REACTION; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG PURITY; DRUG SYNTHESIS; IN VITRO STUDY; MOUSE; NONHUMAN; RADIOACTIVITY; ULTRAFILTRATION; ANIMAL; HUMAN; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN SYNTHESIS; STANDARD; SYNTHESIS; WHOLE BODY IMAGING;

ANIMALS; CARBON RADIOISOTOPES; CELL-FREE SYSTEM; HUMANS; INTERLEUKIN-8; METHIONINE; MICE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BIOSYNTHESIS; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 84855311827     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.07.005     Document Type: Article

References (24)

1. Shimizu Y., Kanamori T., Ueda T. Protein synthesis by pure translation systems. Methods 2005, 36:299-304.
2. Pavlou A.K., Reichert J.M. Recombinant protein therapeutics - success rates, market trends and values to 2010. Nat Biotechnol 2004, 22:1513-1519.
3. Brekke O.H., Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003, 2:52-62.
4. Hwang D.R., Evelhoch J. How the biopharmaceutical industry uses molecular imaging. J Nucl Med 2008, 49:24N-25N.
5. Levin C.S. Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging 2005, 32(Suppl 2):S325-S345.
6. Tolmachev V., Stone-Elander S. Radiolabelled proteins for positron emission tomography: pros and cons of labelling methods. Biochim Biophys Acta 2010, 1800:487-510.
7. Malviya G., Signore A., Lagana B., Dierckx R.A. Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases. Curr Pharm Des 2008, 14:2401-2414.
8. Miller P.W., Long N.J., Vilar R., Gee A.D. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed Engl 2008, 47:8998-9033.
9. Heppeler A., Froidevaux S., Macke H.R., Jermann E., Behe M., Powell P., et al. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy. Chem-Eur J 1999, 5:1974-1981.
10. Velikyan I., Beyer G.J., Langstrom B. Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity. Bioconjug Chem 2004, 15:554-560.
11. Koehler L., Gagnon K., McQuarrie S., Wuest F. Iodine-124: a promising positron emitter for organic PET chemistry. Molecules 2010, 15:2686-2718.
12. Shimizu Y., Inoue A., Tomari Y., Suzuki T., Yokogawa T., Nishikawa K., et al. Cell-free translation reconstituted with purified components. Nat Biotechnol 2001, 19:751-755.
13. Van Damme J., Rampart M., Conings R., Decock B., Van Osselaer N., Willems J., et al. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms. Eur J Immunol 1990, 20:2113-2118.
14. Hebert C.A., Luscinskas F.W., Kiely J.M., Luis E.A., Darbonne W.C., Bennett G.L., et al. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 1990, 145:3033-3040.
15. Schutyser E., Struyf S., Proost P., Opdenakker G., Laureys G., Verhasselt B., et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 2002, 277:24584-24593.
16. Gross M.D., Shapiro B., Fig L.M., Steventon R., Skinner R.W., Hay R.V. Imaging of human infection with (131)I-labeled recombinant human interleukin-8. J Nucl Med 2001, 42:1656-1659.
17. Bleeker-Rovers C.P., Rennen H.J., Boerman O.C., Wymenga A.B., Visser E.P., Bakker J.H., et al. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation. J Nucl Med 2007, 48:337-343.
18. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22:195-201.
19. Kiefer F., Arnold K., Kunzli M., Bordoli L., Schwede T. The SWISS-MODEL repository and associated resources. Nucleic Acids Res 2009, 37:D387-D392.
20. Peitsch M.C. Protein modeling by e-mail. Bio-Technology 1995, 13:658-660.
21. Pascali C., Bogni A., Iwata R., Decise D., Crippa F., Bombardieri E. High efficiency preparation of L-S-methyl-C-11 methionine by on-column C-11 methylation on C18 Sep-Pak. J Label Compd Radiopharm 1999, 42:715-724.
22. Nagren K., Halldin C. Methylation of amide and thiol functions with C-11 methyl triflate, as exemplified by C-11 NMSP, C-11 flumazenil and C-11 methionine. J Label Compd Radiopharm 1998, 41:831-841.
23. Tsukada H., Sato K., Fukumoto D., Nishiyama S., Harada N., Kakiuchi T. Evaluation of d-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with l- and d-11C-methionine. J Nucl Med 2006, 47:679-688.
24. Kiga D., Sakamoto K., Kodama K., Kigawa T., Matsuda T., Yabuki T., et al. An engineered Escherichia coli tyrosyl-tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system. Proc Natl Acad Sci USA 2002, 99:9715-9720.